ArticleMediterranean journal of hematology and infectious diseases2023
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.
Monica Carpenedo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.